Table 4.

GH replacement therapy in GHD and cardiovascular risk: summary of main results.

	GHD(a)	GHD<12m(b)	GHD>12m(c)
Fat free mass	increased	increased	increased	p<0.05
Fat mass	decreased	decreased	decreased	p<0.05
Total cholesterol	neutral	neutral	neutral
LDL cholesterol	decreased	decreased	decreased	p<0.05
HDL cholesterol	neutral	neutral	neutral
Glycemia	neutral	neutral	neutral
HbA1c	neutral	neutral	neutral

(a) Isolated GHD; (b) GHD in panhypopituitarism in stable compensation therapy since less than 12 months; (c) GHD in panhypopituitarism in stable compensation therapy since more than 12 months.